53702 Federal Register / Vol. 75, No. 169 / Wednesday, September 1, 2010 / Notices 

Period of Replacement Award: The 

period of support for the replacement 

award is June 1, 2010 to October 31, 

2010. 

Authority: Section 330(h) of the Public 

Health Service Act, 42 U.S.C. 245b. 

CDFA Number: 93.703. 

Justification for Exception to 

Competition: The former grantee, Saint 

Vincent’s Catholic Medical Centers of 

New York, has relinquished all grants. 

Saint Vincent’s Catholic Medical 

Centers of New York’s inpatient services 

has closed, and Saint Vincent’s Catholic 

Medical Center of New York has filed 

for bankruptcy under Chapter 11. The 

former grantee has requested that HRSA 

transfer the Health Center Program 

Section 330(h) funds to SPHC in order 

to implement and carry out grant 

activities originally proposed under 

SVCMC funded Section 330(h) grant 

applications. 

SPHC has been engaged in the 

delivery of primary health care services 

in the local area and is a current Section 

330 grantee who indicated an ability to 

assume operations without a disruption 

of services. 

The short-term transfer of the 330(h) 

funds will ensure that critical primary 

health care services continue and 

remain available to low-income, 

underserved, homeless patients with no 

interruption in services to the target 

population. 

FOR FURTHER INFORMATION CONTACT: 

Marquita Cullom-Scott via e-mail at 

MCullom-Scott@hrsa.gov or 301–594– 

4300. 

Dated: August 26, 2010. 

Mary K. Wakefield, 

Administrator. 

[FR Doc. 2010–21836 Filed 8–31–10; 8:45 am] 

BILLING CODE 4165–15–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Food and Drug Administration 

[Docket No. 2010–N–0389] 

Medical Device User Fee Act; Public 

Meeting; Request for Comments; 

Amendment of Notice 

AGENCY: Food and Drug Administration, 

HHS. 

ACTION: Notice. 

SUMMARY: The Food and Drug 

Administration (FDA) is announcing an 

amendment to the notice of a public 

meeting on the reauthorization of the 

medical device user fee program. This 

meeting was announced in the Federal 

Register of August 13, 2010 (75 FR 

49502). The amendment is being made 

to include the exact meeting location, 

previously identified only as the 

Washington D.C. metropolitan area. 

There are no other changes. 

FOR FURTHER INFORMATION CONTACT: 

James Swink, Center for Devices and 

Radiological Health, Food and Drug 

Administration, 10903 New Hampshire 

Ave., Bldg. 66, rm. 1609, Silver Spring, 

MD 20993, 301–796–6313, FAX: 301– 

847–8121, email: 

James.Swink@fda.hhs.gov. 

SUPPLEMENTARY INFORMATION: In the 

Federal Register of August 13, 2010 (75 

FR 49502), FDA announced that a 

public meeting on the reauthorization of 

the medical device user fee program 

would be held on September 14, 2010. 

On page 49503, in the first column, the 

Location portion of the document is 

changed to read as follows: 

Location: The meeting will be held at 

the Marriott Inn and Conference Center, 

University of Maryland University 

College (UMUC), 3501 University Blvd. 

East, Hyattsville, MD 20783, 

www.marriott.com/wasum. 

Dated: August 27, 2010. 

David Dorsey, 

Acting Deputy Commissioner for Policy, 

Planning and Budget. 

[FR Doc. 2010–21800 Filed 8–31–10; 8:45 am] 

BILLING CODE 4160–01–S 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Mental Health; 

Amended Notice of Meeting 

Notice is hereby given of a change in 

the meeting of the Services 

Subcommittee of the Interagency 

Autism Coordinating Committee (IACC), 

September 13, 2010, 1 p.m. to 4 p.m., 

National Institute of Mental Health, 

Neuroscience Center, 6001 Executive 

Boulevard, Conference Room A1/A2, 

Rockville, MD 20852, which was 

published in the Federal Register on 

August 19, 2010, 75 FR 51276. 

The meeting will not be Webcast as 

originally advertised. The meeting is 

open to the public and will still be 

accessible through a conference call 

phone number. The meeting will be 

held in the same place and same time. 

Dated: August 25, 2010. 

Jennifer S. Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2010–21817 Filed 8–31–10; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Amended 

Notice of Meeting 

Notice is hereby given of a change in 

the meeting of the Clinical Neuroscience 

and Neurodegeneration Study Section, 

September 30, 2010, 8 a.m. to October 

1, 2010, 5 p.m., Washington Plaza Hotel, 

10 Thomas Circle, NW., Washington, 

DC, 20005 which was published in the 

Federal Register on August 4, 2010, 75 

FR 46950–46951. 

The meeting will be one day only 

September 30, 2010. The meeting time 

and location remain the same. The 

meeting is closed to the public. 

Dated: August 26, 2010. 

Jennifer S. Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2010–21816 Filed 8–31–10; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Notice of 

Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Member 

Conflict: Developmental Biology. 

Date: September 14–15, 2010. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892 

(Virtual Meeting). 

Contact Person: Noni Byrnes, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5130, 

MSC 7840, Bethesda, MD 20892, (301) 435– 

1023, byrnesn@csr.nih.gov. 


hsrobinson on DSK69SOYB1PROD with NOTICES